Evonik has launched the Resomer Precise platform of custom functional polymeric excipients to allow pharmaceutical companies to control the release profile of their parenteral drug products to new levels of accuracy and precision. The new Resomer platform, which is enabled by a sophisticated process technology developed by Evonik, will also help to optimize drug product stability and thereby further reduce regulatory risk for a range of complex parenteral drug products.   Custom excipients wit...